Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases
Journal of Clinical Medicine · 04.05.2023 · 12 (9) · 3271
DOI: 10.3390/jcm12093271 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.05.2023. Verfasst von Oscar Pizano-Martinez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación en Reumatología y del Sistema Músculo-Esquelético (IIRSME), Centro Universitario de Ciencias de la Salud, Universidad de G…. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autoimmune rheumatic diseases are a cluster of heterogeneous disorders that share some clinical symptoms such as pain, tissue damage, immune deregulation, and the presence of inflammatory mediators. Biologic disease-modifying antirheumatic drugs are some of the most effective treatments for rheumatic diseases. However, their molecular and pharmacological complexity makes them potentially immunogenic and capable of inducing the development of anti-drug antibodies. TNF inhibitors appear to be the main contributors to immunogenicity because they are widely used, especially in rheumatoid arthritis. Immunogenicity response on these treatments is crucial since the appearance of ADAs has consequences in terms of safety and efficacy. Therefore, this review proposes an overview of the immunogenicity of biological agents used in autoimmune rheumatic diseases highlighting the prevalence of anti-drug antibodies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Investigación en Reumatología y del Sistema Músculo-Esquelético (IIRSME), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, JAL, Mexico.
- Departamento de Morfología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, JAL, Mexico.
- Cuerpo Académico UDG-CA-703, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, JAL, Mexico.
- Laboratorio Estatal de Salud Pública (LESP), Secretaría de Salud Jalisco, Zapopan 46170, JAL, Mexico.
- Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, JAL, Mexico.
- Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, JAL, Mexico.
ORCID-Profile: Oscar Pizano-Martinez, Edgar Mendieta-Condado, Mónica Vázquez-Del Mercado, Erika Aurora Martínez-García, Efrain Chavarria-Avila, Daniel Ortuño-Sahagún, Ana Laura Márquez-Aguirre
Zitieren
APA
Pizano-Martinez, O., Mendieta-Condado, E., Vázquez-Del Mercado, M., Martínez-García, E. A., Chavarria-Avila, E., Ortuño-Sahagún, D., & Márquez-Aguirre, A. L. (2023). Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases. Journal of Clinical Medicine, 12(9), 3271. https://doi.org/10.3390/jcm12093271
Vancouver
Pizano-Martinez O, Mendieta-Condado E, Vázquez-Del Mercado M, Martínez-García EA, Chavarria-Avila E, Ortuño-Sahagún D, et al. Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases. Journal of Clinical Medicine. 2023;12(9):3271. doi:10.3390/jcm12093271
BibTeX
@article{PizanoMartinez2023,
author = {Pizano-Martinez, Oscar and Mendieta-Condado, Edgar and Vázquez-Del Mercado, Mónica and Martínez-García, Erika Aurora and Chavarria-Avila, Efrain and Ortuño-Sahagún, Daniel and Márquez-Aguirre, Ana Laura},
title = {Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {9},
pages = {3271},
doi = {10.3390/jcm12093271}
}
EUVIMED